Versor Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,206
Closed -$497K 107
2025
Q4
$497K Sell
9,206
-8,504
-48% -$409K 0.08% 329
2025
Q3
$799K Buy
17,710
+9,698
+121% +$453K 0.15% 179
2025
Q2
$371K Buy
+8,012
New +$393K 0.07% 477
2025
Q1
Sell
-21,208
Closed -$1.2M 719
2024
Q4
$1.2M Sell
21,208
-2,592
-11% -$145K 0.21% 109
2024
Q3
$1.23M Buy
23,800
+2,900
+14% +$136K 0.19% 137
2024
Q2
$868K Buy
+20,900
New +$935K 0.16% 184
2024
Q1
Sell
-13,600
Closed -$698K 693
2023
Q4
$698K Buy
13,600
+1,870
+16% +$98.2K 0.14% 228
2023
Q3
$681K Buy
+11,730
New +$719K 0.14% 208
2022
Q4
Sell
-30,579
Closed -$2.17M 736
2022
Q3
$2.17M Sell
30,579
-7,245
-19% -$526K 0.13% 74
2022
Q2
$2.91M Buy
37,824
+34,273
+965% +$2.61M 0.11% 61
2022
Q1
$259K Buy
+3,551
New +$238K 0.01% 524
2021
Q3
Sell
-5,907
Closed -$395K 511
2021
Q2
$395K Sell
5,907
-2,186
-27% -$143K 0.01% 189
2021
Q1
$511K Buy
8,093
+300
+4% +$18.7K 0.03% 131
2020
Q4
$483K Sell
7,793
-10,061
-56% -$619K 0.04% 41
2020
Q3
$1.08M Sell
17,854
-1,200
-6% -$72.2K 0.09% 68
2020
Q2
$1.12M Buy
+19,054
New +$1.14M 0.11% 23
2019
Q1
Sell
-10,520
Closed -$547K 275
2018
Q4
$547K Sell
10,520
-9,980
-49% -$536K 0.13% 149
2018
Q3
$1.27M Buy
+20,500
New +$1.22M 0.48% 64

Other funds holding BMY

Versor Investments's BMY Position: Q1 2026 in Review

Versor Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 9,206 shares — an estimated $497K sold.

Versor Investments first reported a position in BMY in Q3 2018 and held it in 18 quarters. The position peaked at $2.91M in Q2 2022. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Versor Investments reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 9,206 Bristol-Myers Squibb shares in Q1 2026, an estimated $497K.
  • Versor Investments first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 18 quarters.
  • Versor Investments's Bristol-Myers Squibb position peaked at $2.91M in Q2 2022.
  • 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.